SCHEMBL6995989

SCHEMBL6995989

O=[N+]([O-])c1cccc2[nH]c(Cc3nc4c([N+](=O)[O-])cccc4[nH]3)nc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKN1 Q16512 1/20 0.57
PKN2 Q16513 1/20 0.57
ADORA3 P0DMS8 1/20 0.51
GAA P10253 2/20 0.48
MGAM O43451 1/20 0.48
SI P14410 1/20 0.48
MGAM2 Q2M2H8 1/20 0.48
PDE10A Q9Y233 1/20 0.46
NOS1 P29475 4/20 0.44
ALDH1A1 P00352 3/20 0.43
NOS2 P35228 3/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
KDM4E B2RXH2 2/20 0.42
CYP1A2 P05177 2/20 0.42
CYP3A4 P08684 2/20 0.42
MAPT P10636 2/20 0.42
TSHR P16473 2/20 0.42
CYP2C19 P33261 2/20 0.42
BLM P54132 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6998377 0.92 ADORA3 (0.54) PKN1PKN2ADORA3GAAALDH1A1
Hydrochloric Acid SCHEMBL7001387 0.90 ADORA3 (0.53) PKN1PKN2ADORA3GAAALDH1A1
SCHEMBL4888425 0.88 PKN1 (0.55) PKN1PKN2ADORA3GAAMGAM
SCHEMBL3947018 0.88 PKN1 (0.55) PKN1PKN2ADORA3GAAMGAM
SCHEMBL15228495 0.88 PKN1 (0.55) PKN1PKN2ADORA3GAAMGAM
SCHEMBL8598342 0.88 GAA (0.56) PKN1PKN2ADORA3GAAMGAM
SCHEMBL8328888 0.87 PKN1 (0.51) PKN1PKN2ADORA3GAAMGAM
Hydrochloric Acid SCHEMBL4882337 0.86 PKN1 (0.53) PKN1PKN2ADORA3GAAMGAM
SCHEMBL7479338 0.85 PKN1 (0.52) PKN1PKN2ADORA3GAAMGAM
SCHEMBL7486947 0.85 PKN1 (0.52) PKN1PKN2ADORA3GAAMGAM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1189889-B1 COMPOSITIONS AND METHODS FOR INHIBITING CELL DEATH ELAN PHARMA INT LTD (IE) 2003-12-17 EP claimed
EP-1189889-B1 COMPOSITIONS AND METHODS FOR INHIBITING CELL DEATH ELAN PHARMA INT LTD (IE) 2003-12-17 EP disclosed
US-6541486-B1 Used for treating ischemia, such as results from stroke or myocardial infarction, trauma, neurodegeneration, and inflammation. ELAN PHARMA INTERNATIONAL LTD. (IE) 2003-04-01 US disclosed
EP-1189889-A1 COMPOSITIONS AND METHODS FOR INHIBITING CELL DEATH Elan Pharma International Limited (IE) 2002-03-27 EP disclosed
WO-2000075117-A1 COMPOSITIONS AND METHODS FOR INHIBITING CELL DEATH ELAN PHARMA INTERNATIONAL LTD. (IE) 2000-12-14 WO disclosed